• Blog
  • Pricing
  • Contact
  • FAQ
Sign InSign Up
AI Agent for Financial MarketsAsk anything. Our AI Agent brings real-time data and full market coverage.Open chat
MarketsStocksCryptoForexCommoditiesCalendarInsiders
RAPT

RAPT

RAPT Therapeutics, Inc.

NASDAQHealthcareBiotechnologyUS

USD58.01

+0.00 (+0.00%)

Company Profile

CEO

Brian Russell Wong

IPO Date

2019-10-31

Sector

Healthcare

Industry

Biotechnology

Exchange

NASDAQ

Country

US

Market Metrics

Open

$58.01

Prev. Close

$58.01

Day Low

$58.01

Day High

$58.01

52W Low

$5.67

52W High

$58.02

Market Cap

$0.96B

Volume

10.85M

OverviewFinancialsRatingsInsidersSentimentsChart Patterns
News SentimentBullish

Articles

10

Avg Positive

32.0%

Avg Negative

7.6%

Avg Neutral

60.5%

News Feed

RAPT Therapeutics Announces Closing of Public Offering of Common Stock and Full Exercise of Underwriters' Option to Purchase Additional Shares

GlobeNewsWire·6/18/2021·↓ negative

RAPT Therapeutics Announces Pricing of Public Offering of Common Stock

GlobeNewsWire·6/15/2021·↑ positive

RAPT Stock Is Rising, but Don't Call It a Meme Stock

Barrons·6/15/2021
·↑ positive

RAPT Therapeutics (RAPT) is in Overbought Territory: What's Next?

Zacks Investment Research·6/15/2021·↓ negative

RAPT Stock Price Increased 115.51%: Why It Happened

Pulse2·6/15/2021·↑ positive

RAPT Therapeutics Announces Proposed Public Offering of Common Stock

GlobeNewsWire·6/14/2021·↑ positive

Why RAPT Therapeutics Stock Is Surging Today

Benzinga·6/14/2021·↑ positive

RAPT Stock Price Increases Over 80%: Why It Happened

Pulse2·6/14/2021·↑ positive

RAPT Therapeutics to Report Top Line Data from Phase 1b Trial of RPT193 in Atopic Dermatitis

GlobeNewsWire·6/13/2021·↑ positive

RAPT Therapeutics to Present at the UBS Global Healthcare Virtual Conference

GlobeNewsWire·5/20/2021·↑ positive